User: Guest

CANCER GENE THERAPY

Global Market Trajectory & Analytics

MCP10864

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

1928
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

347
Interactions with Platform & by Email

PARTICIPANTS

77
Unique # Participated

VALIDATIONS

36
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEPTEMBER 2020

TABLES

57

PAGES

129

EDITION

5

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for Cancer Gene Therapy estimated at US$611.9 Million in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 29.6% over the analysis period 2020-2027. Oncolytic Virotherapy, one of the segments analyzed in the report, is projected to record a 30.3% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gene Transfer Therapy segment is readjusted to a revised 28.1% CAGR for the next 7-year period.
The Cancer Gene Therapy market in the U.S. is estimated at US$183.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$641.9 Million by the year 2027 trailing a CAGR of 28.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.7% and 25.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.7% CAGR.
In the global Gene-Induced Immunotherapy segment, USA, Canada, Japan, China and Europe will drive the 30.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$89.5 Million in the year 2020 will reach a projected size of US$575.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447 Million by the year 2027.We bring years of research experience to this 5th edition of our report. The 129-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Adaptimmune Therapeutics plc; Advantagene, Inc.; Altor Bioscience (a NANT Company); Anchiano Therapeutics, Inc.; bluebird bio, Inc.; Genelux Corporation; GlaxoSmithKline PLC; Merck & Co., Inc.; OncoGenex Pharmaceuticals, Inc.; Shanghai Sunway Biotech Co., Ltd.; Shenzhen SiBiono GeneTech Co., Ltd.; ZIOPHARM Oncology, Inc.
» Segment (Oncolytic Virotherapy, Gene Transfer Therapy, Gene-Induced Immunotherapy)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Cancer Gene Therapy Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Cancer Gene Therapy Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
Cancer Gene Therapy Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
Cancer Gene Therapy Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Oncolytic Virotherapy (Segment) World Market by Region/Country in US$ Thousand: 2020 to 2027
Oncolytic Virotherapy (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
Oncolytic Virotherapy (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Gene Transfer Therapy (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
Gene Transfer Therapy (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
Gene Transfer Therapy (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Gene-Induced Immunotherapy (Segment) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
Gene-Induced Immunotherapy (Segment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
Gene-Induced Immunotherapy (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Cancer Gene Therapy Market Share (in %) by Company: 2019 & 2025
United States Cancer Gene Therapy Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027
Cancer Gene Therapy Market in the United States by Segment: A Historic Review in US$ Thousand for 2012-2019
United States Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
CANADA
Canadian Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027
Canadian Cancer Gene Therapy Historic Market Review by Segment in US$ Thousand: 2012-2019
Cancer Gene Therapy Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
JAPAN
Japanese Market for Cancer Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027
Cancer Gene Therapy Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019
Japanese Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
CHINA
Chinese Cancer Gene Therapy Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027
Cancer Gene Therapy Historic Market Analysis in China in US$ Thousand by Segment: 2012-2019
Chinese Cancer Gene Therapy Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Cancer Gene Therapy Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Cancer Gene Therapy Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
Cancer Gene Therapy Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
European Cancer Gene Therapy Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027
Cancer Gene Therapy Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019
European Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
FRANCE
Cancer Gene Therapy Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027
French Cancer Gene Therapy Historic Market Scenario in US$ Thousand by Segment: 2012-2019
French Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
GERMANY
Cancer Gene Therapy Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027
German Cancer Gene Therapy Historic Market Analysis in US$ Thousand by Segment: 2012-2019
German Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
ITALY
Italian Cancer Gene Therapy Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027
Cancer Gene Therapy Historic Market Analysis in Italy in US$ Thousand by Segment: 2012-2019
Italian Cancer Gene Therapy Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
United Kingdom Market for Cancer Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027
Cancer Gene Therapy Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019
United Kingdom Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
REST OF EUROPE
Rest of Europe Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027
Cancer Gene Therapy Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019
Rest of Europe Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Cancer Gene Therapy Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027
Asia-Pacific Cancer Gene Therapy Historic Market Scenario in US$ Thousand by Segment: 2012-2019
Asia-Pacific Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
REST OF WORLD
Rest of World Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027
Rest of World Cancer Gene Therapy Historic Market Review by Segment in US$ Thousand: 2012-2019
Cancer Gene Therapy Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
Total Companies Profiled : 7

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com